Bod launches 4 new CBD products under CBII brand in the UK.
CBD and Hemp healthcare products company, Bod AustraliaLimited (ASX: BDA) is pleased to advise that it has launched four new soft-gel capsule products under H&H premium CBII brand in the United Kingdom.
Each of the new soft-gel capsules are designed to benefit specific conditions including stress and anxiety, anti-inflammation, general wellness and liver protection. The products are now available through e-commerce channels, alongside the existing CBII CBD oil range.
The new products utilise unique combinations of CBD, terpenes, vitamins and minerals and are produced in Switzerland under Good Manufacturing Practice conditions. The CBD element is taken from Bod's unique propriety extract, which is grown under Good Agricultural and Collection Practices and produced under GMP conditions guaranteeing a consistent and reproducible extract.
We continue to see steady growth in demand for our CBII product range in the UK so we are very pleased to be launching four new high-quality products to treat a range of mainstream health conditions into this market.Jo Patterson CEO of Bod Australia
"Bod continues to work collaboratively with H&H Group on further additions to the CBII product range and it is expected that further products will be introduced ahead of the planned US expansion, which is scheduled for the second half of this year." Jo Patterson said.
"I look forward to updating shareholders on sales growth in the United Kingdom and on a number of other important developments from within the business over the coming weeks." Added Patterson.
Since launching the CBII brand, Bod has witnessed strong product uptake amongst consumers and has delivered over 48,000 units since December 2019 to date. Given the products are largely purchased via e-commerce channels, Bod has not witnessed any decrease in demand due to the current conditions in the UK.
To learn more about Bod Australia Limited, visit the company HQ here.
Disclaimer: Past performance is not an indicator of future performance.
& Keep Up to Date
Get the latest pot stock recommendations, cannabis news
and industry updates straight to your inbox!